Skip to main content

Inauguration of Oryzon’s new headquarters in Cornellà de Llobregat

By 7 de September de 2009November 18th, 2020No Comments
< Back to news

Inauguration of Oryzon’s new headquarters in Cornellà de Llobregat

The biotech company Oryzon has inaugurated a new 2,300 m2 building in Cornella de Llobregat. This building will accommodate the company's corporate offices and is three times bigger than the space occupied by the company at the Barcelona Science Park (PCB). Relocation to this new site is a response to the company's growth in the past few years, a result of its increased activity and recent acquisition of CrystaX Pharmaceuticals, which have resulted in this company being one of the first three fastest-growing Spanish biotechs in this sector. The inauguration ceremony has been presided by the Minister of Science and Innovation, Cristina Garmendia, and has been graced by the presence of the Innovation, Universities and Enterprise councillor, Josep Huguet, the mayor of Cornellà de Llobregat, Antoni Martinez, and the regent of the Economics and Society Area of the Cornellà city council, Sergi Fernández, as well as representatives of the pharmaceutical and biotech industries of Spain and notable members of the scientific and biomedical communities.

Oryzon focuses its research activity on finding biomarkers for the prevention, diagnosis and treatment of cancer and neurodegenerative diseases, and aims to accelerate the development programmes of new drugs that it is currently carrying out in order to fulfil the commitment to perform clinical trials in 2012. Furthermore, in the next five years, the company wishes to boost its presence and competitiveness at an international level. However, as has been announced by the general director, Carles Buesa, “the company continues and will continue to maintain a close relationship with the Barcelona Science Park, where it still has its own 100 m2 laboratory, and collaborates with several CENIT programmes”.

The firm Oryzon was created in the year 2000 and was the first biotech company founded in Catalonia and one of the first in Spain. In its earliest stages it was part of the first Bioincubator of the Barcelona Science Park (2002-2006), a pioneer project in Spain at that time that was promoted by the PCB, the Bosch i Gimpera Foundation and the CIDEM, and which was born with the objective of boosting the creation and development of new companies with a technological base, in order to promote the creation of a new entrepreneurial tissue in Catalonia and a change in the economic model that would lead to increased social well-being. The project is still in place and currently accommodates a second generation of companies with the support of the Santander Bank.